CEUFAST COURSE

Management of Cardiovascular Disease in Pregnancy

Contact Hour(s): 1 Contact HourAuthor:Kelly LaMonica, DNP(c), MSN, RNC-OB, EFMThis peer-reviewed course is applicable for the following professions: Advanced Practice Registered Nurse (APRN), CCI Credentialed Specialists, Clinical Nurse ...

Course Summary

Contact Hour(s): 

1 Contact Hour

Author:

Kelly LaMonica, DNP(c), MSN, RNC-OB, EFM

This peer-reviewed course is applicable for the following professions: 

Advanced Practice Registered Nurse (APRN), CCI Credentialed Specialists, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN)

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:  

 Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353

Course Description:

Cardiovascular disease is now the leading cause of maternal morbidity and mortality in the United States. Maternal morbidity and mortality rates have remained stable for women with congenital cardiovascular disease, whereas rates have increased for women with acquired cardiovascular disease. This course discusses pregnant and postpartum women with cardiovascular disease, including risk factors, diagnosis, and care planning.

Outcomes:

≥ 92% of participants will understand evidence-based guidelines for caring for pregnant women with cardiovascular disease.

Objectives:

After completing this continuing education course, the participant will be able to:

  1. Identify risk factors for developing cardiovascular disease (CVD).
  2. Summarize cardiac changes in pregnancy.
  3. Outline ways to diagnose CVD in pregnancy.
  4. Compare guidelines for cardiovascular evaluation.
  5. Paraphrase postpartum cardiomyopathy care.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.